Warning: Cannot modify header information - headers already sent by (output started at /home4/theeurek/public_html/amcrasto/wp-config.php:1) in /home4/theeurek/public_html/amcrasto/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home4/theeurek/public_html/amcrasto/wp-config.php:1) in /home4/theeurek/public_html/amcrasto/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home4/theeurek/public_html/amcrasto/wp-config.php:1) in /home4/theeurek/public_html/amcrasto/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home4/theeurek/public_html/amcrasto/wp-config.php:1) in /home4/theeurek/public_html/amcrasto/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home4/theeurek/public_html/amcrasto/wp-config.php:1) in /home4/theeurek/public_html/amcrasto/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home4/theeurek/public_html/amcrasto/wp-config.php:1) in /home4/theeurek/public_html/amcrasto/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home4/theeurek/public_html/amcrasto/wp-config.php:1) in /home4/theeurek/public_html/amcrasto/wp-includes/rest-api/class-wp-rest-server.php on line 1831

Warning: Cannot modify header information - headers already sent by (output started at /home4/theeurek/public_html/amcrasto/wp-config.php:1) in /home4/theeurek/public_html/amcrasto/wp-includes/rest-api/class-wp-rest-server.php on line 1831
{"id":1250,"date":"2014-01-16T10:06:14","date_gmt":"2014-01-16T10:06:14","guid":{"rendered":"http:\/\/amcrasto.theeurekamoments.com\/?p=1250"},"modified":"2014-01-16T10:06:14","modified_gmt":"2014-01-16T10:06:14","slug":"glenmark-conferred-with-best-biotech-new-molecular-entity-patent-award","status":"publish","type":"post","link":"https:\/\/amcrasto.theeurekamoments.com\/2014\/01\/16\/glenmark-conferred-with-best-biotech-new-molecular-entity-patent-award\/","title":{"rendered":"Glenmark conferred with Best Biotech New Molecular Entity Patent award"},"content":{"rendered":"

\"\"<\/p>\n

GLENMARK PHARMA<\/a><\/p>\n

IDMA<\/a>\u00a0best biotech NEW MOLECULAR ENTITY\u00a0patent award to\u00a0Glenmark<\/a><\/p>\n

YEAR 2012-2013 YEAR in Mumbai India<\/p>\n

PATENT \u00a0US 8236315<\/a><\/p>\n

GLENMARK PHARMACEUTICALS, S.A., SWITZERLAND<\/p>\n

INVENTORS<\/p>\n\n\n\n
<\/td>\nElias Lazarides<\/a>,\u00a0Catherine Woods<\/a>,\u00a0Xiaomin Fan<\/a>,\u00a0Samuel Hou<\/a>,\u00a0Harald Mottl<\/a>,\u00a0Stanislas Blein<\/a>,\u00a0Martin Bertschinger<\/a>ALSO PUBLISHED ASCA2712221A1<\/a>,\u00a0CN101932606A<\/a>,EP2245069A1<\/a>,\u00a0US20090232804<\/a>,WO2009093138A1<\/a><\/p>\n\n\n\n
<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n
Publication number<\/td>\nUS8236315 B2<\/td>\n<\/tr>\n
Publication type<\/td>\nGrant<\/td>\n<\/tr>\n
Application number<\/td>\nUS 12\/358,682<\/td>\n<\/tr>\n
Publication date<\/td>\n7 Aug 2012<\/td>\n<\/tr>\n
Filing date<\/td>\n23 Jan 2009<\/td>\n<\/tr>\n
Priority date<\/td>\n23 Jan 2008<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

USPTO<\/a>,\u00a0USPTO Assignment<\/a>,\u00a0Espacenet<\/a>,\u00a0US 8236315<\/a><\/p>\n

The present disclosure relates generally to humanized antibodies or binding fragments thereof specific for human von Willebrand factor (vWF), methods for their preparation and use, including methods for treating vWF mediated diseases or disorders. The humanized antibodies or binding fragments thereof specific for human vWF may comprise complementarity determining regions (CDRs) from a non-human antibody (e.g., mouse CDRs) and human framework regions.<\/p>\n

The present disclosure provides a humanized antibody or binding fragment thereof specific for vWF that comprises a heavy chain variable region sequence as set forth in SEQ ID NO: 19 and a light chain variable region sequence as set forth in SEQ ID NO: 28 ……….. CONT<\/p>\n

\"\"<\/p>\n

MR GLEN SALDANHA<\/p>\n

MD , CEO\u00a0GLENMARK<\/a><\/p>\n

INDIAN DRUG MANUFACTURERS’ ASSOCIATION<\/a>\u00a0\u00a0 (IDMA)<\/h4>\n

102-B Poonam Chambers, Dr A B Road, Worli, Mumbai 400 018, INDIA
\nTel : +91 – 22 – 24944625 \/ 24974308. Fax : ++91 – 22 – 24957023
\nemail: ppr@idmaindia.com website : www.idma-assn.org<\/p>\n","protected":false},"excerpt":{"rendered":"

GLENMARK PHARMA IDMA\u00a0best biotech NEW MOLECULAR ENTITY\u00a0patent award to\u00a0Glenmark YEAR 2012-2013 YEAR in Mumbai India PATENT \u00a0US 8236315 GLENMARK PHARMACEUTICALS, S.A., SWITZERLAND INVENTORS Elias Lazarides,\u00a0Catherine Woods,\u00a0Xiaomin Fan,\u00a0Samuel Hou,\u00a0Harald Mottl,\u00a0Stanislas Blein,\u00a0Martin BertschingerALSO PUBLISHED ASCA2712221A1,\u00a0CN101932606A,EP2245069A1,\u00a0US20090232804,WO2009093138A1 Publication number US8236315 B2 Publication type Grant Application number US 12\/358,682 Publication date 7 Aug 2012 Filing date 23 Jan 2009 Priority… Continue reading Glenmark conferred with Best Biotech New Molecular Entity Patent award<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[118],"tags":[123,122,120,124,155,121],"_links":{"self":[{"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/posts\/1250"}],"collection":[{"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/comments?post=1250"}],"version-history":[{"count":1,"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/posts\/1250\/revisions"}],"predecessor-version":[{"id":1251,"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/posts\/1250\/revisions\/1251"}],"wp:attachment":[{"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/media?parent=1250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/categories?post=1250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amcrasto.theeurekamoments.com\/wp-json\/wp\/v2\/tags?post=1250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}